There are 2789 resources available
164P - Effect of ELOVL5 expression on breast cancer development
Presenter: Trinh Le Vi Kieu
Session: ePoster Display
165P - Pathologic and immunohistochemical prognostic score in residual triple-negative breast cancer after neoadjuvant chemotherapy
Presenter: Silvia Mihaela Ilie
Session: ePoster Display
166P - Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes
Presenter: Marco Bono
Session: ePoster Display
167P - Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
Presenter: Clarissa Filorizzo
Session: ePoster Display
168P - Change in distant DFS events in adjuvant breast cancer trials over time
Presenter: Alexandra Desnoyers
Session: ePoster Display
170P - Identification and validation of novel immune genomic subtypes for triple-positive breast cancer
Presenter: Jian Zheng
Session: ePoster Display
171P - Combining tumor-infiltrating lymphocytes and PD-L1 expression can stratify prognosis in early-stage triple-negative breast cancer patients who did not receive adjuvant chemotherapy
Presenter: Shu Yazaki
Session: ePoster Display
172P - Stage-dependent prognostic value of systemic inflammatory biomarkers in early triple-negative breast cancer (TNBC)
Presenter: Guilherme Nader Marta
Session: ePoster Display
173P - What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis
Presenter: Burak Aktas
Session: ePoster Display